Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT.
Eur J Hybrid Imaging. 2023 Aug 7;7(1):14. doi: 10.1186/s41824-023-00172-7.
Eur J Hybrid Imaging. 2023.
PMID: 37544941
Free PMC article.
Relationship between somatostatin receptor expressing tumour volume and health-related quality of life in patients with metastatic GEP-NET.
Ohlsson H, Gålne A, Trägårdh E, Malmström M, Sundlöv A, Almquist M.
Ohlsson H, et al. Among authors: galne a.
J Neuroendocrinol. 2022 Jun;34(6):e13139. doi: 10.1111/jne.13139. Epub 2022 Apr 29.
J Neuroendocrinol. 2022.
PMID: 35488399
Free PMC article.
Item in Clipboard
Optimal follow-up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours.
Ohlsson H, Spaak E, Gålne A, Sundlöv A, Almquist M.
Ohlsson H, et al. Among authors: galne a.
J Neuroendocrinol. 2024 Aug;36(8):e13396. doi: 10.1111/jne.13396. Epub 2024 Apr 28.
J Neuroendocrinol. 2024.
PMID: 38679928
Item in Clipboard
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors.
Gålne A, Almquist H, Almquist M, Hindorf C, Ohlsson T, Nordenström E, Sundlöv A, Trägårdh E.
Gålne A, et al.
J Nucl Med. 2019 Dec;60(12):1717-1723. doi: 10.2967/jnumed.119.226332. Epub 2019 Apr 18.
J Nucl Med. 2019.
PMID: 31000584
Free PMC article.
Item in Clipboard
Retrospective evaluation of the predictive value of tumour burden at baseline [68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
Gålne A, Sundlöv A, Enqvist O, Sjögreen Gleisner K, Larsson E, Trägårdh E.
Gålne A, et al.
EJNMMI Rep. 2024 Aug 8;8(1):24. doi: 10.1186/s41824-024-00210-y.
EJNMMI Rep. 2024.
PMID: 39112915
Free PMC article.
Item in Clipboard
Cite
Cite